Neuroprotective effect of ebselen on rat hippocampal slices submitted to oxygen-glucose deprivation: Correlation with immunocontent of inducible nitric oxide synthase

Neuroscience Letters

Volumn 346, Issue 1-2, 2003, Pages 101-104

  Porciúncula, Lisiane O ^a   Rocha, João Batista T ^b   Cimarosti, Helena ^a   Vinadé, Lúcia ^c   Ghisleni, Gabriele ^a   Salbego, Christianne G ^a   Souza, Diogo O ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Brain ischemia; Cellular death; Ebselen; Nitric oxide; Oxygen glucose deprivation

Indexed keywords

EBSELEN; NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN LEVEL; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE INTAKE; HIPPOCAMPUS; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

EID: 84984565443     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00580-9     Document Type: Article

References (20)

1. Bredt D.S., Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63:1994;175-195.
2. Cárdenas A., Moro M.A., Hurtado O., Leza J.C., Lorenzo P., Castrillo A., Bodelon O.G., Bosca L., Lizasoain I. Implication of glutamate in the expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. J. Neurochem. 74:2000;2041-2048.
3. Cárdenas A., De Alba J., Moro M.A., Leza J.C., Lorenzo P., Lizasoain I. Protective effect of N-(3-(aminomethyl) benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation. Eur. J. Pharmacol. 354:1998;161-165.
4. Chen H., Li D., Saldeen T., Romeo F., Mehta J.L. Mixed tocopherol preparation is superior to alpha-tocopherol alone against hypoxia-reoxygenation injury. Biochem. Biophys. Res. Commun. 291:2002;349-353.
5. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
6. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
7. Dirnagl U., Lindauer U., Them A., Schreiber S., Pfister H.W., Koedel U., Reszka R., Freyer D., Villringer A. Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo. J. Cereb. Blood Flow Metab. 15:1995;929-940.
8. Endoh M., Maiese K., Wagner J. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global oxygen and glucose deprivation. Brain Res. 651:1994;92-100.
9. Gross S.S., Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57:1995;737-769.
10. Hattori R., Inoue R., Sase K., Eizawa H., Kosuga K., Aoyama T., Masayasu H., Kawai C., Sasayama S., Yui Y. Preferential inhibition of inducible nitric oxide synthase by ebselen. Eur. J. Pharmacol. 267:1994;R1-R2.
11. Herin G.A., Du S., Aizenman E. The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site. J. Neurochem. 78:2001;1307-1314.
12. Imai H., Masayasu H., Dewar D., Graham D.I., Macrae I.M. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke. 32:2001;2149-2154.
13. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79:1999;1431-1568.
14. Müller A., Cadenas E., Graf P., Sies H. A novel biologically active seleno-organic compound I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochem. Pharmacol. 33:1984;3235-3239.
15. Piatandosi C.A., Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke. 27:1996;327-331.
16. Porciúncula L.O., Rocha J.B.T., Boeck C.R., Vendite D., Souza D.O. Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons. Neurosci. Lett. 299:2001;217-220.
17. Rossato J.I., Zeni G., Mello C.F., Rubin M.A., Rocha J.B.T. Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neurosci. Lett. 318:2002;137-140.
18. Schewe C., Schewe T., Wendel A. Strong inhibition of mammalian lipoxygenases by the anti-inflammatory seleno-organic compound ebselen in the absence of glutathione. Biochem. Pharmacol. 48:1994;65-74.
19. Yamaguchi T., Sano K., Takakura K., Saito I., Shinohara Y., Asano T., Yasuhara H. Ebselen in acute ischemic stroke: a placebo-controlled, double-bind clinical trial. Stroke. 29:1998;12-17.
20. Zhao R., Masayasu H., Holmgren A. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc. Natl. Acad. Sci. USA. 99:2002;8579-8584.